Citations

Showing 10 of 108094 citations.

Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis
Barrionuevo, Patricia , Nabhan, Mohammed , Altayar, Osama , Erwin, Patricia J., Asi, Noor, Martin, Kathryn A. , Murad, M. Hassan , Murad, M Hassan , Wang, Zhen , Altayar, Osama

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | March 7, 2018 | Volume: 103 | Issue: 4 | Pages: 1258-1264

10.1210/jc.2017-02052 | PMID 29522176 Get It

Scarring in Patients With PIK3CA-Related Overgrowth Syndromes
Steiner, Jack E. , Cottrell, Catherine E. , Streicher, Jenna L., Jensen, John , King, David M. , Burrows, Patricia E. , Siegel, Dawn H. , Tollefson, Megha M. , Drolet, Beth A. , Püttgen, Katherine B.

Mayo Clinic

JAMA Dermatology | March 7, 2018 | Volume: 154 | Issue: 4 | Pages: 452

10.1001/jamadermatol.2017.6189 | PMID 29516089 Get It

Late Reconstruction of the Interosseous Membrane with Bone-Patellar Tendon-Bone Graft for Chronic Essex-Lopresti Injuries
Gaspar, Michael P. , Adams, Julie E. , Zohn, Ralph C., Jacoby, Sidney M. , Culp, Randall W., Osterman, A. Lee , Kane, Patrick M. , Adams, Julie , Adams, Julie E

Mayo Clinic

Journal of Bone and Joint Surgery | March 7, 2018 | Volume: 100 | Issue: 5 | Pages: 416-427

10.2106/jbjs.17.00820 | PMID 29509619 Get It

Background: The purpose of this study was to report our long-term outcomes following reconstruction of the forearm interosseous membrane (IOM) with bone-patellar tendon-bone (BPTB) graft for treatment of chronic Essex-Lopresti injuries. Methods: We identified 33 patients who underwent IOM reconstruction with BPTB graft for chronic Essex-Lopresti injuries over a 20-year treatment interval. Twenty male and 13 female patients, with a mean age of 42.1 years (range, 19 to 73 years) and a minimum follow-up interval of 5 years, were included. Preinjury clinical examination and radiographic measurements were obtained from records for comparison with prospectively collected data. Additional functional outcome data collected postoperatively included QuickDASH (an abbreviated version of the Disabilities of the Arm, Shoulder and Hand [DASH]), modified Mayo wrist (MMW), and Broberg-Morrey elbow function scores. Results: IOM reconstruction was performed at a mean interval (and standard deviation) of 44.9 ± 60.0 months (range, 6.4 to 208 months) from the time of the initial injury. At a mean follow-up of 10.9 ± 4.4 years (range, 5.5 to 24.2 years), significant improvements were observed in mean elbow flexion-extension arc (+13° [95% confidence interval (CI), 4° to 22°]; p = 0.005), wrist flexion-extension arc (+19° [95% CI, 4° to 34°]; p = 0.016), forearm pronation-supination (+23° [95% CI, 8° to 39°]; p = 0.004), and grip strength (+25% of that of the contralateral side [95% CI, 18% to 32% of contralateral side]; p < 0.001). Improvements in ulnar variance were sustained over the long term from +3.9 mm (95% CI, 3.2 to 4.6 mm) preoperatively to −1.6 mm (95% CI, −2.3 to −0.9 mm) immediately postoperatively and −1.1 mm (95% CI, −1.8 to −0.4 mm) at the time of the final follow-up (p < 0.001). The mean QuickDASH, MMW, and Broberg-Morrey scores were 29.8 (range, 5 to 61), 82.7 (range, 60 to 100), and 91.6 (range, 64 to 100), respectively. Conclusions: IOM reconstruction with a BPTB graft is an effective treatment option for chronic Essex-Lopresti injuries, with satisfactory clinical and functional outcomes over the long term. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
I Am What I Am Because of Who We All Are
Braman, Jonathan P. , Freedman, Brett A. , Gofton, Wade , Hsu, Joseph R. , Sheps, David S., Strauss, Eric J. , Bernthal, Nicholas M

Mayo Clinic

Journal of Bone and Joint Surgery | March 7, 2018 | Volume: 100 | Issue: 5 | Pages: e28

10.2106/jbjs.17.00812 | PMID 29509624 Get It

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline
Martin, Kathryn A. , Anderson, R. Rox, Chang, R. Jeffrey , Ehrmann, David A., Løbo, Rogerio A. , Murad, M. Hassan , Pugeat, Michel, Rosenfield, Robert L. , Murad, M Hassan

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | March 7, 2018 | Volume: 103 | Issue: 4 | Pages: 1233-1257

10.1210/jc.2018-00241 | PMID 29522147 Get It

VEGF-mediated angiogenesis and vascularization of a fumarate-crosslinked polycaprolactone (PCLF) scaffold
Wagner, Eric R. , Parry, Joshua A. , Dadsetan, Mahrokh, Bravo, Dalibel , Riester, Scott M. , Wijnen, André J. van , Yaszemski, Michael J. , Parry, Joshua, van Wijnen, Andre J , Wagner, Eric R , Kakar, Sanjeev

Mayo Clinic

Connective Tissue Research | March 7, 2018 | Volume: 59 | Issue: 6 | Pages: 542-549

10.1080/03008207.2018.1424145 | PMID 29513041 Get It

The Problem of Burnout Among Surgeons
Patti, Marco G. , Sarr, Michael G. , Schlottmann, Francisco

Mayo Clinic

JAMA Surgery | March 7, 2018 | Volume: 153 | Issue: 5 | Pages: 403

10.1001/jamasurg.2018.0047 | PMID 29516082 Get It

QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy
Patel, Salma , Ackerman, Michael J. , Shamoun, Fadi , Geske, Jeffrey B. , Ommen, Steve R. , Love, William T., Cha, Stephen S., Bos, J. Martijn , Lester, Steven J., Patel, Salma I, Shamoun, Fadi E., Bos, Johan M, Bos, Johan M , Geske, Jeffrey B , Cha, Stephen S.

Mayo Clinic

Acta Cardiologica | March 7, 2018 | Volume: 74 | Issue: 1 | Pages: 53-58

10.1080/00015385.2018.1440905 | PMID 29513133 Get It

Disseminated blastomycosis in a transplant patient
Challener, Douglas W. , Saleh, Omar Abu , Challener, Douglas , Abu Saleh, Omar

Mayo Clinic

Transplant Infectious Disease | March 7, 2018 | Volume: 20 | Issue: 2 | Pages: No page available

10.1111/tid.12870 | PMID 29512289 Get It

AbstractA 51‐year‐old woman from Wisconsin with past medical history of kidney transplantation from her sibling 8 weeks prior, presented with symptoms of shortness of breath, cough, and a new skin rash over a 2‐week period.
Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management
Elliott, Michelle A. , Tefferi, Ayalew

Mayo Clinic

American Journal of Hematology | March 7, 2018 | Volume: 93 | Issue: 4 | Pages: 578-587

10.1002/ajh.24983 | PMID 29512199 Get It

AbstractDisease Overview and DiagnosisChronic neutrophilic leukemia (CNL) is a potentially aggressive myeloproliferative neoplasm, for which current WHO diagnostic criteria include leukocytosis of ≥ 25 x 109/L of which ≥ 80% are neutrophils, with < 10% circulating neutrophil precursors with blasts rarely observed. In addition, there is no dysplasia, nor clinical or molecular criteria for other myeloproliferative neoplasms.Update on DiagnosisPreviously the diagnosis of CNL was often as one of exclusion based on no identifiable cause for physiologic neutrophilia in patients fulfilling the aforementioned criteria. The 2016 WHO classification now recognizes somatic activating mutations of CSF3R (most commonly CSF3RT618I) as diagnostic, allowing for an accurate diagnosis for the majority of suspected cases through molecular testing. These mutations are primary driver mutations, accounting for the characteristic clinical phenotype and potential susceptibility to molecularly targeted therapy.Risk StratificationConcurrent mutations, common to myeloid neoplasms and their precursor states, most frequently in SETBP1 and ASXL1, are frequent and appear to be of prognostic significance. Although data are evolving on the full genomic profile, the rarity of CNL has delayed complete understanding of its full molecular pathogenesis and individual patient prognosis.